Form 8-K - Current report:
SEC Accession No. 0001193125-18-207684
Filing Date
2018-06-28
Accepted
2018-06-28 16:33:25
Documents
5
Period of Report
2018-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d801224d8k.htm 8-K 17441
2 EX-1.1 d801224dex11.htm EX-1.1 202029
3 EX-5.1 d801224dex51.htm EX-5.1 6367
4 GRAPHIC g801224img1.jpg GRAPHIC 9481
5 GRAPHIC g801224img2.jpg GRAPHIC 7803
  Complete submission text file 0001193125-18-207684.txt   251237
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 18925775
SIC: 2834 Pharmaceutical Preparations